Published in Front Oncol on August 02, 2012
Metastatic neuroblastoma cancer stem cells exhibit flexible plasticity and adaptive stemness signaling. Stem Cell Res Ther (2015) 1.51
Surviving apoptosis: life-death signaling in single cells. Trends Cell Biol (2015) 0.90
A mechanism linking Id2-TGFβ crosstalk to reversible adaptive plasticity in neuroblastoma. PLoS One (2013) 0.80
The Id-protein family in developmental and cancer-associated pathways. Cell Commun Signal (2017) 0.78
Understanding health and disease with multidimensional single-cell methods. J Phys Condens Matter (2014) 0.76
Combination of Id2 Knockdown Whole Tumor Cells and Checkpoint Blockade: A Potent Vaccine Strategy in a Mouse Neuroblastoma Model. PLoS One (2015) 0.75
Cell-to-cell heterogeneity of EWSR1-FLI1 activity determines proliferation/migration choices in Ewing sarcoma cells. Oncogene (2017) 0.75
Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A (2003) 59.17
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature (2006) 27.91
Identification of a cancer stem cell in human brain tumors. Cancer Res (2003) 24.02
Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol (2006) 23.04
Tumour stem cells and drug resistance. Nat Rev Cancer (2005) 15.21
A perivascular niche for brain tumor stem cells. Cancer Cell (2007) 11.55
Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer (2003) 10.88
Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. N Engl J Med (1999) 9.02
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features. Proc Natl Acad Sci U S A (2009) 7.95
Recent advances in neuroblastoma. N Engl J Med (2010) 7.86
A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth. Cell (2010) 6.47
Cancer despite immunosurveillance: immunoselection and immunosubversion. Nat Rev Immunol (2006) 6.13
Tumor heterogeneity: causes and consequences. Biochim Biophys Acta (2009) 5.90
Cancer stem cells: impact, heterogeneity, and uncertainty. Cancer Cell (2012) 5.44
Screening of infants and mortality due to neuroblastoma. N Engl J Med (2002) 4.00
Survival of the fittest: cancer stem cells in therapeutic resistance and angiogenesis. J Clin Oncol (2008) 3.84
In vivo switching of human melanoma cells between proliferative and invasive states. Cancer Res (2008) 3.66
The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype. Cell Cycle (2009) 3.55
Coordinate morphological and biochemical interconversion of human neuroblastoma cells. J Natl Cancer Inst (1983) 3.27
Notch promotes radioresistance of glioma stem cells. Stem Cells (2010) 3.07
Autophagy in cancer associated fibroblasts promotes tumor cell survival: Role of hypoxia, HIF1 induction and NFκB activation in the tumor stromal microenvironment. Cell Cycle (2010) 2.80
Heterogeneity maintenance in glioblastoma: a social network. Cancer Res (2011) 2.66
Cancer stem cells in radiation resistance. Cancer Res (2007) 2.59
Metformin decreases the dose of chemotherapy for prolonging tumor remission in mouse xenografts involving multiple cancer cell types. Cancer Res (2011) 2.53
Cancer stem cells and self-renewal. Clin Cancer Res (2010) 2.37
Jekyll and Hyde: the role of the microenvironment on the progression of cancer. J Pathol (2010) 2.14
Epithelial-mesenchymal transition (EMT) in tumor-initiating cells and its clinical implications in breast cancer. J Mammary Gland Biol Neoplasia (2010) 2.00
Infant cancer in the U.S.: histology-specific incidence and trends, 1973 to 1992. J Pediatr Hematol Oncol (1997) 1.87
Brain-derived neurotrophic factor activation of TrkB induces vascular endothelial growth factor expression via hypoxia-inducible factor-1alpha in neuroblastoma cells. Cancer Res (2006) 1.53
Disseminated neuroblastoma in children older than one year at diagnosis: comparable results with three consecutive high-dose protocols adopted by the Italian Co-Operative Group for Neuroblastoma. J Clin Oncol (2003) 1.47
The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/beta-catenin pathway. Oncogene (2009) 1.37
Pancreatic cancer stem cells - update and future perspectives. Mol Oncol (2010) 1.14
Development of resistance to vincristine and doxorubicin in neuroblastoma alters malignant properties and induces additional karyotype changes: a preclinical model. Int J Cancer (2003) 1.12
Treatment resistance in stem cells and breast cancer. J Mammary Gland Biol Neoplasia (2009) 1.10
PDGF-B Can sustain self-renewal and tumorigenicity of experimental glioma-derived cancer-initiating cells by preventing oligodendrocyte differentiation. Neoplasia (2011) 1.00
Increased expression of the hedgehog signaling pathway in pediatric solid malignancies. J Pediatr Surg (2010) 1.00
Changes in microtubules, microtubule-associated proteins, and intermediate filaments during the differentiation of HL-60 leukemia cells. Cancer Res (1992) 0.96
Nestin expression in repopulating mesangial cells promotes their proliferation. Lab Invest (2008) 0.96
Microtubule-associated protein-2 is a sensitive marker of primary and metastatic neuroblastoma. Am J Surg Pathol (2009) 0.91
Association of telomerase activity with radio- and chemosensitivity of neuroblastomas. Radiat Oncol (2010) 0.90
Activation of a prometastatic gene expression program in hypoxic neuroblastoma cells. Endocr Relat Cancer (2009) 0.90
Hedgehog signaling pathway in neuroblastoma differentiation. J Pediatr Surg (2010) 0.86
Prognostic and biological role of neurotrophin-receptor TrkA and TrkB in neuroblastoma. Klin Padiatr (2000) 0.86
High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma. Cochrane Database Syst Rev (2010) 0.86
Inhibition of the sonic hedgehog pathway by cyplopamine reduces the CD133+/CD15+ cell compartment and the in vitro tumorigenic capability of neuroblastoma cells. Cancer Lett (2011) 0.86
Absence of polysialylated NCAM is an unfavorable prognostic phenotype for advanced stage neuroblastoma. BMC Cancer (2009) 0.85
The doublecortin gene, a new molecular marker to detect minimal residual disease in neuroblastoma. Diagn Mol Pathol (2005) 0.85
The studies on the correlation for gene expression of tyrosine-kinase receptors and vascular endothelial growth factor in human neuroblastomas. J Pediatr Hematol Oncol (2010) 0.79
Clinical and biologic characteristics for recurring neuroblastoma at mass screening cases in Japan. Cancer (2001) 0.78
Telomerase expression as complementary prognostic factor in neuroblastoma. J Egypt Natl Canc Inst (2010) 0.76
Cold atmospheric plasma for the ablative treatment of neuroblastoma. J Pediatr Surg (2013) 1.27
rs660 polymorphism in Ro52 (SSA1; TRIM21) is a marker for age-dependent tolerance induction and efficiency of alloimmunization in sickle cell disease. Mol Immunol (2009) 1.16
Induction and regulation of tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand-mediated apoptosis in renal cell carcinoma. Cancer Res (2002) 1.10
Select forms of tumor cell apoptosis induce dendritic cell maturation. J Leukoc Biol (2004) 1.08
Experience with alternate sources of venous inflow in the meso-Rex bypass operation: the coronary and splenic veins. J Pediatr Surg (2007) 1.05
H-type congenital tracheoesophageal fistula: University Of Iowa experience 1985 to 2005. Ann Otol Rhinol Laryngol (2007) 1.00
Pediatric malignancies: neuroblastoma, Wilm's tumor, hepatoblastoma, rhabdomyosarcoma, and sacroccygeal teratoma. Surg Clin North Am (2012) 0.97
Protein kinase Cdelta regulates antigen receptor-induced lytic granule polarization in mouse CD8+ CTL. J Immunol (2007) 0.97
Survivin mRNA levels are associated with biology of disease and patient survival in neuroblastoma: a report from the children's oncology group. J Pediatr Hematol Oncol (2006) 0.95
T-cell receptor signaling events triggering granule exocytosis. Crit Rev Immunol (2006) 0.91
Sampling of major histocompatibility complex class I-associated peptidome suggests relatively looser global association of HLA-B*5101 with peptides. Hum Immunol (2006) 0.91
Immune stimulatory antigen loaded particles combined with depletion of regulatory T-cells induce potent tumor specific immunity in a mouse model of melanoma. Cancer Immunol Immunother (2008) 0.90
Characterization of the transcriptional expression of Notch-1 signaling pathway members, Deltex and HES-1, in developing mouse thymocytes. Dev Comp Immunol (2002) 0.89
Survivin inhibits apoptosis induced by TRAIL, and the ratio between survivin and TRAIL receptors is predictive of recurrent disease in neuroblastoma. J Pediatr Surg (2006) 0.89
Cutting edge: developmental up-regulation of IFN-gamma-inducible lysosomal thiol reductase expression leads to reduced T cell sensitivity and less severe autoimmunity. J Immunol (2009) 0.88
Use of autogenous saphenous vein as a conduit for mesenterico-left portal vein bypass. J Pediatr Surg (2007) 0.87
Surgical excision combined with autologous whole tumor cell vaccination is an effective therapy for murine neuroblastoma. J Pediatr Surg (2006) 0.87
Growth retardation as well as spleen and thymus involution in latent TGF-beta binding protein (Ltbp)-3 null mice. J Cell Physiol (2003) 0.86
Activation of primary T lymphocytes results in lysosome development and polarized granule exocytosis in CD4+ and CD8+ subsets, whereas expression of lytic molecules confers cytotoxicity to CD8+ T cells. J Leukoc Biol (2006) 0.84
Adaptable TCR avidity thresholds for negative selection. J Immunol (2008) 0.83
The association of CD81 polymorphisms with alloimmunization in sickle cell disease. Clin Dev Immunol (2013) 0.83
Characterization of signaling function and expression of HLA class I molecules in medulloblastoma. J Neurooncol (2010) 0.83
Survivin mRNA is down-regulated during early Xenopus laevis embryogenesis. Dev Dyn (2002) 0.82
Survivin expression in juvenile-onset recurrent respiratory papillomatosis. Ann Otol Rhinol Laryngol (2002) 0.82
A novel role of HLA class I in the pathology of medulloblastoma. J Transl Med (2009) 0.81
Prognostic value of quantifying apoptosis factor expression in favorable histology wilms tumors. J Pediatr Hematol Oncol (2005) 0.80
Surgical treatment of a gastric diverticulum in an adolescent. J Pediatr Surg (2006) 0.79
CpG oligonucleotides for immunotherapeutic treatment of neuroblastoma. Adv Drug Deliv Rev (2009) 0.78
Increased incidence of perforated appendicitis in children with obesity. Clin Pediatr (Phila) (2012) 0.78
Robotic resection of mediastinal masses in children. J Laparoendosc Adv Surg Tech A (2008) 0.78
Age-related accumulation of T cells with markers of relatively stronger autoreactivity leads to functional erosion of T cells. BMC Immunol (2012) 0.77
Immunostimulatory sutures that treat local disease recurrence following primary tumor resection. Biomed Mater (2011) 0.76
Management of congenital chest wall deformities. Semin Plast Surg (2011) 0.75
Altered functional balance of Gfi-1 and Gfi-1b as an alternative cause of reticular dysgenesis? Med Hypotheses (2009) 0.75
Immune stimulation for the treatment of papilloma. Ann Otol Rhinol Laryngol (2005) 0.75
Effective adoptive therapy of tap-deficient lymphoma using diverse high avidity alloreactive T cells. Cancer Immunol Immunother (2009) 0.75
Delineation of signals required for thymocyte positive selection. J Immunol (2004) 0.75
Paternal cell immunization raises autoantibodies and improves pregnancy success in mice. Am J Reprod Immunol (2008) 0.75
Elevated plasma vascular endothelial growth factor levels in 2 patients with hemangioendothelioma. J Pediatr Surg (2005) 0.75